NO963255L - Sykliske neurokinin-A antagonister - Google Patents

Sykliske neurokinin-A antagonister

Info

Publication number
NO963255L
NO963255L NO963255A NO963255A NO963255L NO 963255 L NO963255 L NO 963255L NO 963255 A NO963255 A NO 963255A NO 963255 A NO963255 A NO 963255A NO 963255 L NO963255 L NO 963255L
Authority
NO
Norway
Prior art keywords
antagonists
neurokinin
cyclic
cyclic neurokinin
antagonism
Prior art date
Application number
NO963255A
Other languages
English (en)
Other versions
NO963255D0 (no
Inventor
Thomas Joseph Owen
Elizabeth Mary Kudlacz
Stephen Henderson Buck
Scott Lee Harbeson
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NO963255D0 publication Critical patent/NO963255D0/no
Publication of NO963255L publication Critical patent/NO963255L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/22Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Antagonister av neurokinin A som er nye sykliske hexapeptid- og octapeptidforbindelser, er beskrevet. Antagonismen er bekreftet under anvendelse av konvensjonelle konkur- rerende bindings- og kjemiske bestemmelser så vel som konvensjo- nelle fysiologiske tester, og anvendelse av disse derivater i et utall av tilstander hvori neuro- kinin A er involvert, er også beskrevet. Forbindelse av formelen SEQ. ID l hvori R er benzyl, p-hydroxybenzyl eller 3-indolylmethyl; R. er benzy]., 3-indolylmethyl eller (ca^) --CONH-; R- er C, 5 lineær eller forgrenet alkyl og X er H, eller R, og X er forbundet sammen for å danne -(CH,),-; R. er H, benzyl, 3-indolylmethyl eller p-hydroxybenzyl; R,, er H, methyl eller 3-indolylmethyl; forutsatt at når R_ er (CH_)--CONH-, er R, p-hydroxybenzyl og carbonet til hvilket R, er bundet, er i en (R) absolutt konfigurasjon; eller et hydrat, stereoisomer, isoster eller farmasøytisk akseptabelt salt derav.
NO963255A 1994-02-03 1996-08-02 Sykliske neurokinin-A antagonister NO963255L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/191,571 US5521156A (en) 1994-02-03 1994-02-03 Cyclic neurokinin A antagonists
PCT/US1995/000296 WO1995021187A1 (en) 1994-02-03 1995-01-10 Cyclic neurokinin a antagonists

Publications (2)

Publication Number Publication Date
NO963255D0 NO963255D0 (no) 1996-08-02
NO963255L true NO963255L (no) 1996-10-02

Family

ID=22706020

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963255A NO963255L (no) 1994-02-03 1996-08-02 Sykliske neurokinin-A antagonister

Country Status (19)

Country Link
US (1) US5521156A (no)
EP (1) EP0741743B1 (no)
JP (2) JPH09511490A (no)
KR (3) KR100378726B1 (no)
CN (1) CN1139931A (no)
AT (1) ATE172205T1 (no)
AU (1) AU691246B2 (no)
CA (1) CA2182486C (no)
DE (1) DE69505351T2 (no)
DK (1) DK0741743T3 (no)
ES (1) ES2123234T3 (no)
FI (1) FI963074A (no)
HU (1) HUT74383A (no)
IL (1) IL112489A0 (no)
MX (1) MX9603194A (no)
NO (1) NO963255L (no)
NZ (1) NZ279595A (no)
WO (1) WO1995021187A1 (no)
ZA (1) ZA95710B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830863A (en) * 1988-06-20 1998-11-03 Merrell Pharmaceuticals Inc. Neurokinin A antagonists
US5744120A (en) * 1993-03-30 1998-04-28 The Dupont Merick Pharmaceutical Company Ternary radiopharmaceutical complexes
US5521156A (en) * 1994-02-03 1996-05-28 Merrell Pharmaceuticals Inc. Cyclic neurokinin A antagonists
US5879659A (en) * 1996-03-13 1999-03-09 Dupont Pharmaceuticals Company Ternary radiopharmaceutical complexes
MX9709494A (es) * 1996-12-04 1998-07-31 Pfizer Compuestos peptidicos ciclicos, procedimiento para su produccion, composiciones que los contienen y uso de los mismos.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4102877A (en) * 1976-07-28 1978-07-25 Merck & Co., Inc. Cyclization of peptides
US4659691A (en) * 1985-02-08 1987-04-21 Merck & Co., Inc. Novel cyclic Hexapeptide LHRH antagonists
IT1233696B (it) * 1989-05-29 1992-04-14 Menarini Farma Ind Peptidi di sintesi antagonisti della neurochinina a. loro sali e relativi procedimenti di fabbricazione
IT1241761B (it) * 1990-08-03 1994-02-01 Menarini Farma Ind Peptidi di sintesi antagonisti della neurochinina a, loro sali e relativi procedimenti di fabbricazione
ATE155486T1 (de) * 1991-08-13 1997-08-15 Takeda Chemical Industries Ltd Zyklische peptide und ihre verwendung
US5521156A (en) * 1994-02-03 1996-05-28 Merrell Pharmaceuticals Inc. Cyclic neurokinin A antagonists

Also Published As

Publication number Publication date
DE69505351D1 (de) 1998-11-19
KR100380872B1 (ko) 2003-04-18
JP2005089471A (ja) 2005-04-07
US5521156A (en) 1996-05-28
JPH09511490A (ja) 1997-11-18
CN1139931A (zh) 1997-01-08
EP0741743B1 (en) 1998-10-14
EP0741743A1 (en) 1996-11-13
IL112489A0 (en) 1995-03-30
HU9602157D0 (en) 1996-09-30
ATE172205T1 (de) 1998-10-15
FI963074A0 (fi) 1996-08-02
AU1677195A (en) 1995-08-21
FI963074A (fi) 1996-08-02
MX9603194A (es) 1997-05-31
WO1995021187A1 (en) 1995-08-10
DE69505351T2 (de) 1999-06-02
NO963255D0 (no) 1996-08-02
AU691246B2 (en) 1998-05-14
NZ279595A (en) 1997-12-19
KR100378726B1 (ko) 2003-10-04
DK0741743T3 (da) 1999-06-23
HUT74383A (en) 1996-12-30
CA2182486C (en) 2002-10-08
KR100380873B1 (ko) 2003-04-18
CA2182486A1 (en) 1995-08-10
ZA95710B (en) 1995-10-16
ES2123234T3 (es) 1999-01-01

Similar Documents

Publication Publication Date Title
LV12639B (lv) Bifenilsulfonamidi ka duali angiotenzina un endotelina receptoru antagonisti
EA199700186A1 (ru) Новые дипептидные амидины, используемые в качестве ингибиторов тромбина
FI960727A (fi) Neurokiniiniantagonisteina käyttökelpoiset heterosyklit
EA200300873A1 (ru) Новая соль сукцинат o-десметилвенлафаксина
EA199700118A1 (ru) Трициклические диазепины в качестве антагонистов вазопрессина, способ их получения и способ лечения с использованием трициклических диазепинов
YU104690A (sh) Supstituisani imidazo-kondenzovani 6-člani heterocikli kao antagonisti angiotenzina 2
TR200001603T2 (tr) Yeni bileşikler
TR199900318T2 (xx) IL-8 resept�r antagonistleri.
NO893431L (no) Fremgangsmaate for fremstilling av neuropeptid y antagonister.
SE9702773D0 (sv) Novel compounds
TR199700834T1 (xx) 1-Aril-2-Akilamino ethan bile�ikleri ve bunlar�n n�rokinin olarak �zellikle n�rokinin 1 has�mlar� olarak kullan�mlar�.
TR199900363T2 (xx) NK1 ve NK2 antagonistleri olarak asilaminoalkenilen-amid t�revleri.
DE69839767D1 (de) Verwendung von 15-keto-prostaglandin-e verbindungen als endothelin antagonisten
DE69505351D1 (de) Zyklische neurokinin a - antagonisten
ATE259825T1 (de) Hemihydrat von 16.alpha.-bromoepiandrosterone
CA2022740A1 (en) Cyclic neurokinin a antagonists
EP0347802A3 (en) Neurokinin a antagonists
MX9603199A (es) Antagonistas de receptores a endotelina.
TR200000602T2 (tr) Yeni karbonik asit türevleri, üretimleri ve kullanımları.
DE68905075D1 (de) Herstellung von tris(2-zyanaethyl)amin.
ATE114310T1 (de) Alpha-adrenergische rezeptorantagonisten.
FI905922A0 (fi) Antagonister foer a-adrenerga receptorer.
ID27964A (id) Turuna-azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya